New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Green Innovations Ltd (OTC:GNIN), Athersys, Inc (NASDAQ:ATHX), Endeavour Silver Corp (NYSE:EXK), Antares Pharma Inc (NASDAQ:ATRS)
Green Innovations Ltd (OTC:GNIN) showed a volume of 2.03 million shares by the end of last trade whereas the average volume of the stock remained 1.99 million shares. The stock opened the session at $1.68 but then moved to $1.66. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Is GNIN a Solid Investment at These Levels? Read This Report For Details
Athersys, Inc (NASDAQ:ATHX) opened the session at $4.15 and closed the session at $4.17. The stock showed a positive performance of 2.96% in previous trading session. Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem,
For How Long ATHX will fight for Profitability? Read This Trend Analysis report
Endeavour Silver Corp (NYSE:EXK) opened the session at $4.13 and closed the session at $4.45. The stock showed a positive performance of 3.49% in previous trading session. The beta of the stock remained 0.84. Endeavour Silver Corp. (Endeavour) is engaged in the evaluation, acquisition, exploration, development and exploitation of silver mining properties in Mexico and in exploration in Chile. The Company’s producing mines include Guanacevi mine, Bolanitos Mine and El Cubo.
Why Should Investors Buy EXK After The Recent Gain? Just Go Here and Find Out
Antares Pharma Inc (NASDAQ:ATRS) the stock advanced 2.48% and finished the session at $4.95. Traded with volume of 2.03 million shares in the prior session and the average volume of the stock remained 1.47 million shares. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products.
Will ATRS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)